Codelivery of SH-aspirin and curcumin by mPEG-PLGA nanoparticles enhanced antitumor activity by inducing mitochondrial apoptosis

References

• JemalABrayFCenterMMFerlayJWardEFormanDGlobal cancer statisticsCA Cancer J Clin2011612699021296855
   PubMed Web of Science ®Google Scholar
• VaughanSCowardJIBestRCJrRethinking ovarian cancer: recommendations for improving outcomesNat Rev Cancer2011111071972521941283
   PubMed Web of Science ®Google Scholar
• EganMEPearsonMWeinerSACurcumin, a major constituent of turmeric, corrects cystic fibrosis defectsScience2004304567060060215105504
   PubMed Web of Science ®Google Scholar
• GoelAKunnumakkaraABAggarwalBBCurcumin as “Curecumin”: from kitchen to clinicBiochem Pharmacol200875478780917900536
   PubMed Web of Science ®Google Scholar
• JagetiaGCAggarwalBB“Spicing up” of the immune system by cur-cuminJ Clin Immunol2007271193517211725
   PubMed Web of Science ®Google Scholar
• MaheshwariRKSinghAKGaddipatiJSrimalRCMultiple biological activities of curcumin: a short reviewLife Sci200678182081208716413584
   PubMed Web of Science ®Google Scholar
• LiLBraitehFSKurzrockRLiposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesisCancer200510461322133116092118
   PubMed Web of Science ®Google Scholar
• ChoudhuriTPalSAgwarwalMLDasTSaGCurcumin induces apoptosis in human breast cancer cells through p53-dependent Bax inductionFEBS Lett20025121–333434011852106
   PubMed Web of Science ®Google Scholar
• DoraiTCaoYCDoraiBButtyanRKatzAETherapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivoProstate200147429330311398177
   PubMed Web of Science ®Google Scholar
• RaoCVRivensonASimiBReddyBSChemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compoundCancer Res19955522592667812955
   PubMed Web of Science ®Google Scholar
• BhartiACDonatoNSinghSAggarwalBBCurcumin (diferuloyl-methane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosisBlood200310131053106212393461
   PubMed Web of Science ®Google Scholar
• TianBWangZZhaoYEffects of curcumin on bladder cancer cells and development of urothelial tumors in a rat bladder carcinogenesis modelCancer Lett2008264229930818342436
   PubMed Web of Science ®Google Scholar
• ShiMCaiQYaoLMaoYMingYOuyangGAntiproliferation and apoptosis induced by curcumin in human ovarian cancer cellsCell Biol Int200630322122616376585
   PubMed Web of Science ®Google Scholar
• ClarkCAMcEachernMDShahSHCurcumin inhibits carcinogen and nicotine-induced Mammalian target of rapamycin pathway activation in head and neck squamous cell carcinomaCancer Prev Res (Phila)20103121586159520851953
   PubMed Web of Science ®Google Scholar
• AnandPNairHBSungBDesign of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivoBiochem Pharmacol201079333033819735646
   PubMed Web of Science ®Google Scholar
• WilkenRVeenaMSWangMBSrivatsanESCurcumin: a review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinomaMol Cancer2011101221299897
   PubMed Web of Science ®Google Scholar
• AggarwalBBHarikumarKBPotential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseasesInt J Biochem Cell Biol2009411405918662800
   PubMed Web of Science ®Google Scholar
• AggarwalBBKumarABhartiACAnticancer potential of cur-cumin: preclinical and clinical studiesAnticancer Res2003231A36339812680238
   PubMed Web of Science ®Google Scholar
• ShishodiaSSethiGAggarwalBBCurcumin: getting back to the rootsAnn N Y Acad Sci2005105620621716387689
   PubMed Web of Science ®Google Scholar
• AgrawalDKMishraPKCurcumin and its analogues: potential anticancer agentsMed Res Rev201030581886020027668
   PubMed Web of Science ®Google Scholar
• ZhouHBeeversCSHuangSThe targets of curcuminCurr Drug Targets201112333234720955148
   PubMed Web of Science ®Google Scholar
• KrishnanKRuffinMTNormolleDColonic mucosal prostaglandin E2 and cyclooxygenase expression before and after low aspirin doses in subjects at high risk or at normal risk for colorectal cancerCancer Epidemiol Biomarkers Prev200110544745311352853
   PubMed Web of Science ®Google Scholar
• RuffinMT4thKrishnanKRockCLSuppression of human colorectal mucosal prostaglandins: determining the lowest effective aspirin doseJ Natl Cancer Inst19978915115211609262254
   PubMedGoogle Scholar
• HuangMTLouYRMaWNewmarkHLReuhlKRConneyAHInhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in miceCancer Res19945422584158477954412
   PubMed Web of Science ®Google Scholar
• ProfitaMSalaABonannoAChronic obstructive pulmonary disease and neutrophil infiltration: role of cigarette smoke and cyclooxygenase productsAm J Physiol Lung Cell Mol Physiol20102982L261L26919897740
   PubMed Web of Science ®Google Scholar
• SinicropeFAHalfEMorrisJSFamilial Adenomatous Polyposis Study GroupCell proliferation and apoptotic indices predict adenoma regression in a placebo-controlled trial of celecoxib in familial adenomatous polyposis patientsCancer Epidemiol Biomarkers Prev200413692092715184247
   PubMed Web of Science ®Google Scholar
• CarrollREBenyaRVTurgeonDKPhase IIa clinical trial of curcumin for the prevention of colorectal neoplasiaCancer Prev Res (Phila)20114335436421372035
   PubMed Web of Science ®Google Scholar
• KashfiKAnti-inflammatory agents as cancer therapeuticsAdv Pharmacol200957318920230759
   PubMedGoogle Scholar
• ChattopadhyayMKodelaROlsonKRKashfiKNOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell growth in vitro and in a xenograft mouse modelBiochem Biophys Res Commun2012419352352822366248
   PubMed Web of Science ®Google Scholar
• ChattopadhyayMNathNKodelaRHydrogen sulfide-releasing aspirin inhibits the growth of leukemic Jurkat cells and modulates β-catenin expressionLeuk Res201337101302130823896061
   PubMed Web of Science ®Google Scholar
• ChattopadhyayMKodelaRNathNHydrogen sulfide-releasing NSAIDs inhibit the growth of human cancer cells: a general property and evidence of a tissue type-independent effectBiochem Pharmacol201283671572222222427
   PubMed Web of Science ®Google Scholar
• ChattopadhyayMKodelaRNathNBarsegianABoringDKashfiKHydrogen sulfide-releasing aspirin suppresses NF-κB signaling in estrogen receptor negative breast cancer cells in vitro and in vivoBiochem Pharmacol201283672373222209867
   PubMed Web of Science ®Google Scholar
• KodelaRChattopadhyayMKashfiKNOSH-Aspirin: A Novel Nitric Oxide-Hydrogen Sulfide-Releasing Hybrid: a new class of anti-inflammatory pharmaceuticalsACS Med Chem Lett20123325726222916316
   PubMed Web of Science ®Google Scholar
• ZhangLChanJMGuFXSelf-assembled lipid – polymer hybrid nanoparticles: a robust drug delivery platformACS Nano2008281696170219206374
   PubMed Web of Science ®Google Scholar
• GouMWeiXMenKPCL/PEG copolymeric nanoparticles: potential nanoplatforms for anticancer agent deliveryCurr Drug Targets20111281131115021443476
   PubMed Web of Science ®Google Scholar
• WangXYangLChenZGShinDMApplication of nanotechnology in cancer therapy and imagingCA Cancer J Clin20085829711018227410
   PubMed Web of Science ®Google Scholar
• WenYGallegoMRNielsenLFJorgensenLMøllerEHNielsenHMDesign and characterization of core-shell mPEG-PLGA composite microparticles for development of cell-scaffold constructsEur J Pharm Biopharm2013851879823958320
   PubMed Web of Science ®Google Scholar
• PengKTChenCFChuIMTreatment of osteomyelitis with teicoplanin-encapsulated biodegradable thermosensitive hydrogel nanoparticlesBiomaterials201031195227523620381140
   PubMed Web of Science ®Google Scholar
• AcharyaSSahooSKPLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effectAdv Drug Deliv Rev201163317018320965219
   PubMed Web of Science ®Google Scholar
• SongXZhaoYHouSDual agents loaded PLGA nanoparticles: systematic study of particle size and drug entrapment efficiencyEur J Pharm Biopharm200869244545318374554
   PubMed Web of Science ®Google Scholar
• ZhaoLWientjesMGAuJLEvaluation of combination chemotherapy: integration of nonlinear regression, curve shift, isobologram, and combination index analysesClin Cancer Res200410237994800415585635
   PubMed Web of Science ®Google Scholar
• GreenDRReedJCMitochondria and apoptosisScience19982815381130913129721092
   PubMed Web of Science ®Google Scholar
• WuLZhangJWatanabeWPhysical and chemical stability of drug nanoparticlesAdv Drug Deliv Rev201163645646921315781
   PubMed Web of Science ®Google Scholar
• GouMMenKShiHCurcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivoNanoscale2011341558156721283869
   PubMed Web of Science ®Google Scholar
• ZhangYTangLSunLA novel paclitaxel-loaded poly(epsilon-caprolactone)/Poloxamer 188 blend nanoparticle overcoming multidrug resistance for cancer treatmentActa Biomater2010662045205219969111
   PubMed Web of Science ®Google Scholar
• YanFZhangCZhengYThe effect of poloxamer 188 on nanoparticle morphology, size, cancer cell uptake, and cytotoxicityNanomedicine20106117017819447200
   PubMed Web of Science ®Google Scholar
• GelperinaSKisichKIsemanMDHeifetsLThe potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosisAm J Respir Crit Care Med2005172121487149016151040
   PubMed Web of Science ®Google Scholar
• HuCMZhangLTherapeutic nanoparticles to combat cancer drug resistanceCurr Drug Metab200910883684120214578
   PubMed Web of Science ®Google Scholar
• ZhuHChenHZengXCo-delivery of chemotherapeutic drugs with vitamin E TPGS by porous PLGA nanoparticles for enhanced chemotherapy against multi-drug resistanceBiomaterials20143572391240024360574
   PubMed Web of Science ®Google Scholar
• ChengDCaoNChenJYuXShuaiXMultifunctional nanocarrier mediated co-delivery of doxorubicin and siRNA for synergistic enhancement of glioma apoptosis in ratBiomaterials20123341170117922061491
   PubMed Web of Science ®Google Scholar
• WangHZhaoYWuYEnhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticlesBiomaterials201132328281829021807411
   PubMed Web of Science ®Google Scholar
• HuCMAryalSZhangLNanoparticle-assisted combination therapies for effective cancer treatmentTher Deliv20101232333422816135
   PubMedGoogle Scholar
• CreixellMPeppasNACo-delivery of siRNA and therapeutic agents using nanocarriers to overcome cancer resistanceNano Today20127436737926257819
   PubMed Web of Science ®Google Scholar
• DengXCaoMZhangJHyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancerBiomaterials201435144333434424565525
   PubMed Web of Science ®Google Scholar
• ShengYLiuCYuanYLong-circulating polymeric nanoparticles bearing a combinatorial coating of PEG and water-soluble chitosanBiomaterials200930122340234819150737
   PubMed Web of Science ®Google Scholar
• YokoyamaMOkanoTSakuraiYEkimotoHShibazakiCKataokaKToxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in bloodCancer Res19915112322932362039998
   PubMed Web of Science ®Google Scholar
• AbouzeidAHPatelNRTorchilinVPPolyethylene glycol-phosphatidylethanolamine (PEG-PE)/vitamin E micelles for co-delivery of paclitaxel and curcumin to overcome multi-drug resistance in ovarian cancerInt J Pharm20144641–217818424440402
   PubMedGoogle Scholar
• CarlsonLJCoteBAlaniAWRaoDAPolymeric micellar co-delivery of resveratrol and curcumin to mitigate in vitro doxorubicin-induced cardiotoxicityJ Pharm Sci201410382315232224914015
   PubMed Web of Science ®Google Scholar
• PeiYWuBCaoQWuLYangGHydrogen sulfide mediates the anti-survival effect of sulforaphane on human prostate cancer cellsToxicol Appl Pharmacol2011257342042822005276
   PubMed Web of Science ®Google Scholar
• TrachoothamDLuWOgasawaraMANilsaRDHuangPRedox regulation of cell survivalAntioxid Redox Signal20081081343137418522489
   PubMed Web of Science ®Google Scholar
• Attene-RamosMSWagnerEDGaskinsHRPlewaMJHydrogen sulfide induces direct radical-associated DNA damageMol Cancer Res20075545545917475672
   PubMed Web of Science ®Google Scholar
• StaskoABrezovaVZaliberaMBiskupicSOndriasKElectron transfer: a primary step in the reactions of sodium hydrosulphide, an H2S/HS(−) donorFree Radic Res200943658159319513906
   PubMed Web of Science ®Google Scholar
• Attene-RamosMSWagnerEDPlewaMJGaskinsHREvidence that hydrogen sulfide is a genotoxic agentMol Cancer Res20064191416446402
   PubMed Web of Science ®Google Scholar
• PredmoreBLLeferDJGojonGHydrogen sulfide in biochemistry and medicineAntioxid Redox Signal201217111914022432697
   PubMed Web of Science ®Google Scholar